Bellerophon Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
16 Oct 2023	Form 4: Puissance Capital Management Lp, 10% owner and 3 others Sold 1,076,841 shares ($112K)
09 Jun 2023	Form 4: Amin Naseem, Director Received 47,578 shares as a grant or award
09 Jun 2023	Form 4: Fernandes Peter, See Remarks Disposed of 100,000 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Shah Parag Suresh, VP of Business Operations Disposed of 50,000 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Dekker Martin, See Remarks Disposed of 50,000 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Bruder Scott P, Director Disposed of 14,607 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Kim Bobae, VP Reg. Affairs & Quality Disposed of 50,000 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Wang Theodore T, Director Disposed of 14,607 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Cloyd Mary Ann, Director Disposed of 14,607 Stock Options (Right to Buy) (Grant/Award Acquisition)
09 Jun 2023	Form 4: Teufel Crispin, Director Disposed of 14,607 Stock Options (Right to Buy) (Grant/Award Acquisition)
07 Jun 2023	Form 4: Puissance Life Science Opportunities Fund Vi, 10% owner and 3 others Sold 134,421 shares ($112K)
22 May 2023	Form 4: Kim Bobae, VP Reg. Affairs & Quality Received 1,288 shares by exercise or conversion ($9.62K) · Sold 9,455 shares ($94.6K)
19 May 2023	Form 4: Puissance Life Science Opportunities Fund Vi, 10% owner and 3 others Sold 560,000 shares ($5.3M)
14 Feb 2023	Form 4: Amin Naseem, Director Received 84,000 shares as a grant or award
14 Feb 2023	Form 4: Teufel Crispin, Director Granted 29,000 Stock Options (right to buy) ($44.1K)
14 Feb 2023	Form 4: Dekker Martin, VP OF ENGINEERING & MANUFACTUR Granted 50,000 Stock Options (right to buy) ($76K)
14 Feb 2023	Form 4: Shah Parag Suresh, VP OF BUSINESS OPERATIONS Granted 50,000 Stock Options (right to buy) ($76K)
14 Feb 2023	Form 4: Fernandes Peter, CHIEF EXECUTIVE OFFICER Granted 100,000 Stock Options (right to buy) ($152K)
14 Feb 2023	Form 4: Laccona Nicholas, FINANCIAL OFFICER, (PFO & PAO) Granted 50,000 Stock Options (right to buy) ($76K)
14 Feb 2023	Form 4: Wang Theodore T, Director Granted 29,000 Stock Options (right to buy) ($44.1K)

Comments